Leonard M. Miller Professor and Chairman
Department of Psychiatry and Behavioral Sciences
Clinical Director, Center on Aging
University of Miami Leonard M. Miller School of Medicine
Known for his work in treating depression, Dr. Nemeroff has conducted research on the biological basis of the major neuropsychiatric disorders, including affective disorders, schizophrenia, and anxiety disorders. His clinical research focuses on the use of genetic, neuroendocrine, neuroimaging, and neurochemical methods to understand comprehensively the pathophysiology of depression.
His wide research interests include the neuroscience of major psychiatric disorders, antidepressant drug discovery, the psychobiology of corticotrophin-releasing factor; and pancreatic cancer, depression, and immune function. He has uncovered many of the neurobiological mechanisms that mediate the increased risk for depression and PTSD in victims of child abuse. He has also contributed seminal findings to the growing field of research about the relationship of depression to cardiovascular disease, as well as identifying predictors of specific antidepressant treatments. He has published more than 1000 scientific articles and 15 books including serving as co-editor of the Textbook of Psychopharmacology. Dr. Nemeroff is a member of the National Academy of Medicine and sits on the Board of Directors and Scientific Council of the American Foundation for Suicide Prevention. He is the 2016 recipient of the Julius Axelrod Mentorship Award from the American College of Neuropsychopharmacology and Chair of the ADAA Career Development Leadership Program. He is co-editor in chief of a new journal, Personalized Medicine in Psychiatry published by Elsevier.
Dr. Nemeroff has been an ADAA member since 1999.
Why am I an ADAA member?
I have been a member of ADAA since its inception. It is a unique organization comprised of clinicians and scientists of various backgrounds. This provides a rich environment for professional interactions.
What do I value about the ADAA mission and how does my work fit into the ADAA mission?
ADAA has done a terrific job in educating the lay public on the nature of, and seriousness of mood and anxiety disorders. Being able to connect patients and providers with evidence-based treatments is of extraordinary importance.
What is the thing that I think is most exciting/interesting about what is currently happening in my lab or workplace?
The long awaited goal of precision or personalized medicine in psychiatry—being able to predict the best treatment for individual patients is within our grasp.